Hiroaki Ihara

524 citations
31 papers · 307 · h-index 11

Impact in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Medical Imaging and Pathology Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 12
    • Lung Cancer Treatments and Mutations 3
    • Mycobacterium research and diagnosis 5
    • Pneumonia and Respiratory Infections 3

Hiroaki Ihara

25 papers receiving 303 citations

Peers

Hiroaki Ihara
Comparison fields: 5 of 66
  • Pulmonary and Respiratory Medicine 185
  • Oncology 63
  • Physiology 47
  • Epidemiology 48
  • Microbiology 1
Replace Alan Tan with:
Alan Tan United States
Junyan Qu China
Fachao Zhi China
Noriyuki Horiguchi Japan
Zamir Kadija Italy
Dong-zhu Zeng China
Gaik W. Tew United States
Minchao Duan China
Wataru Saitoh Japan
Antonia R. Sepulveda United States
Hiroaki Ihara relative to Alan Tan United States Alan Tan's profile →
Citations per field
00.5×5.5×
Alan Tan · 1×
Citations per year

Countries citing papers authored by Hiroaki Ihara

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ihara more than expected).

Fields of papers citing papers by Hiroaki Ihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ihara. The network helps show where Hiroaki Ihara may publish in the future.

Co-authors

The 25 scholars most cited alongside Hiroaki Ihara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroaki Ihara Line = papers co-authored together Hiroaki Ihara links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201959
2 201941
3 201830
4 201924
5 201820
6 202020
7 202116
8 202013
9 201912
10 201711
11 202011
12 201910
13 20169
14 20137
15 20244
16 20234
17 20184
18 20213
19 20192
20 20142

About Hiroaki Ihara

Hiroaki Ihara is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Physiology, Infectious Diseases and Molecular Biology, having authored 31 papers that have together received 307 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Tuberculosis Research and Epidemiology (5 papers), Mycobacterium research and diagnosis (5 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers), Quinazolinone synthesis and applications (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (185 citations), Oncology (63 citations), Physiology (47 citations), Epidemiology (48 citations) and Microbiology (1 citation). Hiroaki Ihara has collaborated with scholars based in Japan and China. Frequent co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Motoyasu Kato, Shinichi Sasaki, Kana Kurokawa, Yusuke Ochi, Tomoko Yamada, Takahiro Nakamura, Ken Tajima and Shigeo Takumi. Their work appears in journals such as Scientific Reports, Drug Design Development and Therapy, Lung, Vaccine and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact